VR
Vinitha Rani Rayappan Sarasam
About Vinitha Rani Rayappan Sarasam
Data last updated:
Vinitha Rani Rayappan Sarasam has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Mastek Products Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Mastek Products Private Limited at ₹1.72 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mastek Products Private Limited U74999TN2021PTC141518 | Director | 20 Feb 2021 | 2021 | ₹1.72 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vinitha Rani Rayappan Sarasam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vinitha Rani Rayappan Sarasam
Vinitha Rani Rayappan Sarasam has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Mastek Products Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Mastek Products Private Limited at ₹1.72 Cr (FY 2025).
Vinitha Rani Rayappan Sarasam is associated with 1 company as Director, including Mastek Products Private Limited (₹1.72 Cr).
Vinitha Rani Rayappan Sarasam has expertise in General Business.
Vinitha Rani Rayappan Sarasam has 5 years in corporate governance.
By reported revenue, the largest current company of Vinitha Rani Rayappan Sarasam is Mastek Products Private Limited, with revenue of ₹1.72 Cr (FY 2025).
Vinitha Rani Rayappan Sarasam currently holds positions at 1 company: Mastek Products Private Limited (₹1.72 Cr).